Minotaur Exploration Limited Overview
Andromeda Metals is an Adelaide-based, pre-revenue industrial and critical-minerals developer. Its anchor asset is the 100%-owned Great White Project (GWP) on South Australia's Eyre Peninsula, a high-purity kaolin deposit. GWP has a 15.1 Mt ore reserve, a 28-year mine life, granted mining and miscellaneous-purpose leases, and binding offtake covering the initial Stage 1A+ (100 ktpa). That offtake is led by the commodity merchant Traxys.
The company came to own 100% of Great White by absorbing Minotaur Exploration in 2022. Since then it has added a second leg: a proprietary process that makes 4N (≥99.99%) high-purity alumina (HPA) directly from Great White kaolin. A 2025 scoping study put this at a pre-tax NPV10 of about A$1.48 billion, and the process was validated at continuous pilot scale in August 2026.
Against this technical progress, Andromeda faces an acute funding gap. It needs about A$40 million of equity, alongside a credit-approved A$75 million Merricks Capital debt facility, to reach a final investment decision (FID). It held about A$3.2 million in cash at 30 June 2026, and its FY2026 accounts carry a going-concern material uncertainty.
What the company does
Andromeda is a single-jurisdiction (South Australia) development company with two linked value streams.
1. Refined kaolin (Great White Project).
Process: Ore is mined from ML 6532 near Poochera and wet-processed on site. Refining removes quartz and impurities to produce dried, bagged, high-brightness kaolin products.
Lead product: Great White CRM™, a ceramics-grade refined kaolin for high-end ceramics such as porcelain and sanitaryware.
Other products: Great White KCM™90 (a premium ceramics/coatings grade); Great White HRM™ (a refined halloysite-kaolin product used as a rheology modifier and as an additive to help decarbonise concrete); and industrial sand co-products.
2. High-purity alumina (HPA Project).
Process: A proprietary flowsheet makes 4N HPA directly from refined Great White kaolin. Conventional routes use aluminium metal (the alkoxide process) or smelter-grade alumina as feedstock.
End markets: LEDs, lithium-ion battery separator coatings, semiconductors and electronics, synthetic sapphire, and advanced ceramics.
By-products under evaluation: amorphous silica and gallium.
Business and revenue model
| Dimension | Characterisation |
|---|---|
| Current revenue | Nil operating revenue (FY2022–FY2026). Barchart records about US$27k of FY2025 "sales", likely sample or incidental income |
| Planned revenue model | 100% product sales (physical minerals). No service, subscription or licensing revenue. A possible future licensing angle for the HPA process is not disclosed |
| Sales channel | Through a merchant/offtaker: Traxys Europe S.A. buys Great White CRM™ and HRM™ for the first 5 years (binding agreement, July 2024). Earlier direct offtake with Plantan Yamada Co Ltd for Japan (June 2023). Traxys North America is the proposed HPA route into the US (non-binding HoA, August 2026) |
| Pricing | Years 1–2 of Traxys offtake priced consistent with 2023 feasibility-study assumptions. Year 3 onward set by annual negotiation, with the audited weighted-average sales price as fallback. Upside on Traxys on-sales is shared 50/50 |
| Value-chain position | Upstream miner/processor of industrial minerals, moving into chemical refining (HPA), a midstream critical-mineral product |
| Customer types | Ceramics manufacturers (Europe, Japan, India/Middle East via Traxys), concrete/cement additive users, and for HPA, battery separator, LED/sapphire and semiconductor supply chains |
| End markets | Ceramics (tiles, sanitaryware, tableware), construction (concrete), and technology/energy-transition (HPA) |
Company's own description
In its June 2026 quarterly report, Andromeda describes its activity as advancing two things in parallel: the Great White Project, and its critical-mineral HPA Project, which it intends to commercialise using its proprietary process with high-quality Great White kaolin as feedstock (paraphrased, ADN Quarterly Activity Report, 31 July 2026).
In the half-year report to 31 December 2024, management stated the primary focus as advancing the Great White Project.
Independent characterisation
Andromeda is a funding-constrained, development-ready single-asset company. Its strategic narrative has shifted from a niche industrial mineral (kaolin, where demand is steady but low-growth) towards a critical mineral (HPA, higher growth and policy support).
The engineering, permitting and offtake work on GWP is largely complete. The binding constraint is capital: market value (about A$31M) is a fraction of the remaining equity requirement (about A$40M). In practice the company's equity is now an option on a funding event, most plausibly an asset-level investment from a cornerstone investor.
The roughly A$99M non-cash write-down in FY2026 is the clearest accounting sign that the carrying value of the project had diverged from what the market and funding conditions would support.
Strategy
Stated strategy (paraphrased from 2024–2026 filings)
-
Bring GWP into production, starting with Stage 1A+ (100 ktpa). Secure the balance of funding for FID, execute the Merricks facility and resume construction.
-
Commercialise HPA from Great White kaolin. Use the proprietary process to create a second, higher-margin critical-minerals business. Use pilot samples to secure customers, then complete a PFS.
-
Maintain capital discipline. Implement cost savings (about A$3M identified), defer non-critical engineering, and use the R&D tax incentive.
-
Grow the kaolin portfolio over time. Explore Eyre Kaolin JV and Mt Hope for future feed. Gold/copper exploration has been exited.
Initiatives announced in the last 24 months
| Date | Initiative | Target / detail | Status |
|---|---|---|---|
| Jul 2024 | Binding Traxys offtake | 5-year CRM/HRM offtake supporting Stage 1A+ | In force (subject to production) |
| Jul 2024 | Eyre Kaolin JV earn-in | 51% earned; option to 80% for a further A$2M by November 2027 | Ongoing |
| Jun 2025 | Merricks Capital A$75M debt facility | Covers principal, capitalised interest, fees, reserves and a cost-overrun tranche | Credit-approved; documentation subject to equity close |
| Sep 2025 | HPA Scoping Study | 10,000 tpa; NPV10 about A$1.48bn | Completed |
| Nov 2025 – Jun 2026 | GWP early works | Access, earthworks, drilling, long-lead logistics | Completed; detailed design partly on hold |
| 2025–26 | Global cornerstone equity process | Asset-level investment in GWP and HPA from a Middle East-based investor; due diligence complete | Delayed by geopolitical events |
| Mar 2026 | Cost programme | About A$3M of savings across early works, procurement and administration | Implemented |
| Jun–Aug 2026 | HPA pilot plant | Commissioning, then 4N at continuous scale | Achieved 24 August 2026 |
| Aug 2026 | Traxys North America HPA HoA | US HPA supply pathway linked to Project Vault | Non-binding |
| H2 2026 | HPA customer sampling and PFS | Samples in H2 2026; PFS subject to funding | Pending |
| 2,026 | Assessment of "funding, strategic and corporate opportunities" | Signals openness to corporate transactions | Ongoing |
Guidance and targets
Funding: equity balance for Stage 1A+ FID of about A$40M (indicative), excluding possible effects of recent geopolitical events on diesel pricing or availability.
Production timing: Invest SA once indicated mining in H2 2026. This is no longer realistic absent FID (analyst view).
HPA: commercial 4N samples in H2 2026.
No medium-term financial targets: (revenue, margin) have been issued. Aggregator consensus once showed a A$34M profit in 2027 (Simply Wall St, one analyst, dated 2025). Treat this as stale.
Products & Services
Great White Project (kaolin)
| Product | Description | Key specification / capability | Target customer | Status / year | Pricing |
|---|---|---|---|---|---|
| Great White CRM™ | Refined, dried, bagged ceramics-grade kaolin | High brightness/whiteness suited to premium porcelain and sanitaryware; validated by global ceramics experts per company | European, Japanese, Indian and Middle Eastern ceramics makers (via Traxys) | Pre-production. Traxys contract years: 25,000 wmt year 1, 40,000 wmt year 2, then a higher base from year 3 (±10% at Traxys's option) | Years 1–2 at 2023 DFS assumptions; then annual negotiation; 50/50 upside sharing |
| Great White KCM™90 | Premium refined kaolin grade | Higher-specification ceramics/coatings use; identified as a core product in H1 FY2024 | Specialty ceramics/coatings | Pre-production; earlier offtake for 5,000 t in year 1 under prior agreements | — |
| Great White HRM™ | Refined halloysite-kaolin additive | Rheology modifier; additive to help decarbonise concrete | Concrete and construction chemicals | Traxys: 5,000 wmt in year 1, then 10,000 wmt/yr. Some HRM offtakes conditional on market acceptance | — |
| Industrial sand co-products | By-product quartz sand | Complementary product | Construction/industrial users | Pre-production | — |
| Source | Capex (AUD Mn) | NPV (AUD Mn) | IRR |
|---|---|---|---|
| Stockhead / MST Access summary | 194 (three stages) | 763 | 43% |
| ADN H1 FY2024 report | Not stated | About 1,010 pre-tax (65% improvement, 28-year life) | Not stated |
Project specification:
Location and tenure: ML 6532 (319 ha), MPL 163 for the water pipeline (78 ha), MPL 164 for the access road (13 ha), near Poochera on the Eyre Peninsula, South Australia.
Development stages: Stage 1A+ at 100 ktpa; Stage 1B adding 110 ktpa; Stage 2 adding 120 ktpa (total about 330 ktpa).
Mine life and reserve: 28-year life; ore reserve 15.1 Mt.
Long-lead equipment, status at 30 June 2026: - Fluid bed dryer, thickener and filter press: factory acceptance tested and stored in Australia.
-
Drum washer: factory acceptance tested and warehoused overseas.
-
Filter cake feeder: design complete; fabrication to start after FID.
Water supply: SA Water pipeline to be funded and built by Andromeda, then handed to SA Water.
Feasibility economics (2023 DFS) — conflicting figures. Two sets of numbers circulate, and the difference likely reflects pre-tax versus post-tax figures or an updated case. Not reconciled here.
Stage 1A+ funding was framed by Invest SA as A$90M, including A$84M of capex, plus financing costs.
HPA Project
| Item | Detail |
|---|---|
| Product | 4N high-purity alumina (≥99.99% Al₂O₃), in amorphous and crystalline alpha forms |
| Process | Proprietary flowsheet starting directly from kaolin. HPA patent moved from the PCT phase into national phase (June 2026 quarter) |
| Purity achieved | 99.9985% at laboratory scale (2025). 99.9986% at continuous pilot scale (24 August 2026), with total metallic impurities of 14.47 ppm by GDMS, independently analysed by EAG Laboratories (Eurofins) |
| Scoping Study (18 September 2025) | 10,000 tpa 4N HPA from about 30,000 tpa kaolin; ramp of 2,500 tpa per year to full rate in year 4; 24-year life. Capex: about A$155M pre-production (about A$159M total incl. about 30% contingency); capital intensity A$15,459/t. Costs and margins: opex A$4,718/t; assumed price A$31,250/t; cash margin A$26,532/t. Value: pre-tax NPV10 about A$1.48bn; average annual EBITDA about A$247M. Emissions: 6.47 tCO₂/t HPA, 48% below the alkoxide route |
| Next steps | Commercial samples for customer evaluation in H2 2026; Pre-Feasibility Study (PFS) subject to funding |
| Co-products | Amorphous silica and gallium under evaluation |
| Target customers | Battery separator coaters, LED/sapphire makers, semiconductor/electronics; US critical-mineral supply chain via Traxys North America (Project Vault alignment) |
| Pricing | Not publicly disclosed beyond the scoping assumption |
Exploration and other assets
| Asset | Description | Interest |
|---|---|---|
| Eyre Kaolin JV | Four ELs (Aspen, Whistler, Hotham, Thredbo) near GWP with complementary kaolin; Chairlift drill samples from 2025 still awaiting analysis | 51%; can earn a further 29% (to 80%) by spending A$2M by November 2027 |
| Mt Hope Kaolin (EL 6286) | Kaolin exploration | 100% |
| GWP regional ELs (Tootla, Mt Hall, Mt Cooper) | Regional kaolin exploration | 100% |
| Streaky Bay Pilot Plant | Sample preparation and testing facility | 100% (asset) |
| Legacy Wudinna / Moonta | Gold/copper assets divested in 2024; small retained areas | Retained portions only |
| Camel Lake halloysite-kaolin | Listed by aggregators; not in the June 2026 tenement schedule | — |
Financial Narrative
Source unless stated: S&P Global Market Intelligence via StockAnalysis (FY2026 income statement updated 29 September 2026; balance sheet to 31 December 2025), cross-checked with TipRanks, Barchart and Kalkine. FY2026 cash flow figures come from the ADN Appendix 5B for the quarter to 30 June 2026 (12-month year-to-date). All figures are A$M unless stated.
Income statement
Margins and growth. Gross, operating, EBITDA and net margins are not meaningful because revenue is nil. Revenue CAGR is not meaningful.
Balance sheet
Full FY2026 year-end balance sheet detail was not available in sources reviewed, so FY2021–FY2025 are shown. Interim points follow in 6.2a.
6.2a Interim and latest balance-sheet points
Restricted security: A$90k Westpac credit-card facility, secured against term deposits (A$10k drawn at 30 June 2026). Andromeda has no borrowings. The Merricks A$75M facility is credit-approved but not executed or drawn.
Cash flow
FY2026 Appendix 5B detail (12 months to 30 June 2026):
Operating: exploration and evaluation expensed -A$1.995M; administration and corporate -A$3.923M; government grants and tax incentives +A$0.644M.
Investing: PP&E -A$1.877M; capitalised E&E -A$7.034M; investments -A$3.790M; disposal proceeds +A$1.012M.
Financing: equity proceeds A$14.026M; transaction costs -A$1.036M.
Funding runway: estimated quarters of funding available at 30 June 2026 was 0.98.
Ratios (derived from tables above)
Ratios not meaningful:
-
ROIC: not meaningful (negative NOPAT, minimal invested debt).
-
Net debt/EBITDA: not meaningful (net cash, negative EBITDA).
-
Interest coverage: not meaningful (cash interest paid only about A$0.01–0.03M a year).
-
Asset turnover: 0 (no revenue).
-
Cash conversion cycle: not meaningful.
FY2026 ROE/ROA cannot be computed from primary data without year-end equity. Using H1 FY2026 equity as a proxy, FY2026 ROE is roughly -92% (derived, indicative only), driven by the write-down.
Commentary on trends, inflections and drivers
FY2022 — the balance sheet step-change. Total assets rose about tenfold (A$17.8M to A$174.2M) and contributed equity rose by about A$162M. The causes were the scrip acquisition of Minotaur, which consolidated 100% of Great White and Natural Nanotech and was recorded largely in project assets, plus about A$43M of financing inflows at peak market valuation. Cash peaked at A$32.9M.
FY2023 — peak spend. Free cash outflow peaked at -A$17.7M and R&D at A$2.84M as the DFS and pilot work were completed. This was the year of maximum technical de-risking.
FY2024–FY2025 — cash conservation. Andromeda cut burn, divested gold/copper (Moonta, Wudinna) and raised modest equity in FY2025 (about A$7.9M net financing). Cash fell to A$5.4M at 30 June 2024, a low point that forced the strategy towards external project finance. Merricks credit approval followed in June 2025.
FY2026 — inflection to distress. Three things happened together:
-
Andromeda raised about A$14M (including the A$13M placement) and committed most of it to early works and long-lead equipment, which is irreversible spending ahead of FID.
-
The planned Middle East cornerstone investment stalled after geopolitical events in the region.
-
The carrying value of GWP was written down by about A$99M.
Year-end cash of A$3.2M was below one quarter's outgoings, and the auditor flagged a going-concern material uncertainty.
Drivers. The financial trajectory is driven almost entirely by the timing and terms of project finance, not by operations.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Revenue
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Great White Project revenue (AUD Mn) | 0 | 0 | 0 |
HPA Project revenue (AUD Mn) | 0 | 0 | 0 |
Total operating revenue (AUD Mn) | 0 | 0 | 0 |
Results by Segment
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Group operating income (AUD Mn) | -7.54 | -5.94 | -105.28 |
Group EBITDA (AUD Mn) | -6.45 | -5.62 | -6.18 |
Group Entities
| Entity | Role | Ownership |
|---|---|---|
Andromeda Metals Limited | Listed parent | — |
Andromeda Industrial Minerals Pty Ltd (AIM) | Holder of GWP mining lease ML 6532, MPLs 163/164, ELs 6588/6202/6426 | 100% |
Andromeda Industrial Minerals Holdings Pty Ltd | Holding company | 100% |
Andromeda Industrial Minerals NZ Pty Ltd | Holder of Mt Hope EL 6286 | 100% |
Eyre Kaolin Pty Ltd | 51% participant in Eyre Kaolin JV (Peninsula Exploration Pty Ltd holds 49%) | 100% |
Peninsula Resources Pty Ltd | Legacy gold/copper tenement holder (small retained areas) | 100% |
Minotaur Exploration Pty Ltd | Former MEP, acquired 2022 | 100% |
Natural Nanotech Pty Ltd | Halloysite nanotech R&D vehicle, consolidated after the Minotaur acquisition | — |
Income Statement and Share Count (M)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Gross profit (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
SG&A (AUD Mn) | 5.38 | 7.45 | 6.63 | 4.99 | 5.33 |
R&D expense (AUD Mn) | 0.85 | 2.84 | 0.82 | 0.73 | 0.90 |
Operating income (AUD Mn) | -8.41 | -9.89 | -7.54 | -5.94 | -105.28 |
EBITDA (AUD Mn) | -7.88 | -8.94 | -6.45 | -5.62 | -6.18 |
D&A incl. impairment (AUD Mn) | 0.52 | 0.94 | 1.09 | 0.32 | 99.10 |
Pre-tax income (AUD Mn) | -8.73 | -11.01 | -8.03 | -6.04 | -105.03 |
Net income (AUD Mn) | -8.73 | -9.46 | -7.27 | -6.04 | -105.03 |
Weighted avg shares basic (M) | 2,662 | 3,110 | 3,110 | 3,418 | 4,362 |
EPS basic (A$ cents, derived) | -0.33 | -0.30 | -0.23 | -0.18 | -2.41 |
EPS diluted (A$ cents, derived) | -0.33 | -0.30 | -0.23 | -0.18 | -2.41 |
Dividends per share (A$ cents) | 0 | 0 | 0 | 0 | 0 |
Balance Sheet and Share Count (M)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (AUD Mn) | 17.76 | 174.22 | 165.03 | 158.07 | 160.21 |
Cash & equivalents (AUD Mn) | 4.90 | 32.85 | 15.30 | 5.44 | 7.14 |
PP&E incl. capitalised project assets (AUD Mn) | 11.53 | 139.50 | 144.84 | 149.94 | 150.59 |
Total current assets (AUD Mn) | 5.76 | 34.35 | 19.89 | 6.14 | 8.79 |
Total current liabilities (AUD Mn) | 1.21 | 2.32 | 2.24 | 2.72 | 1.93 |
Total liabilities (AUD Mn) | 1.27 | 3.03 | 2.87 | 3.19 | 2.27 |
Total debt, leases only (AUD Mn) | 0.08 | 0.85 | 0.73 | 0.58 | 0.37 |
Short-term debt (AUD Mn) | 0.06 | 0.17 | 0.20 | 0.22 | 0.21 |
Long-term debt (AUD Mn) | 0.03 | 0.68 | 0.53 | 0.37 | 0.15 |
Net debt, negative = net cash (AUD Mn) | -4.82 | -32.01 | -14.57 | -4.85 | -6.78 |
Shareholders' equity (AUD Mn) | 16.49 | 171.19 | 162.16 | 154.88 | 157.93 |
Goodwill & intangibles (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Working capital (AUD Mn) | 4.55 | 32.03 | 17.65 | 3.43 | 6.86 |
Shares outstanding, period end (M) | 2,159 | 3,106 | 3,108 | 3,108 | 3,813 |
Balance Sheet and Share Count (M) (31 Mar 2026–31 Dec 2025 (H1 FY2026))
| Metric | 31 Dec 2025 (H1 FY2026) | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|
Cash (AUD Mn) | 10.06 | 5.20 | 3.196 |
Total assets (AUD Mn) | 71.66 | — | — |
PP&E / project assets (AUD Mn) | 54.35 | — | — |
Equity (AUD Mn) | 69.62 | — | — |
Shares outstanding (M) | 4,621 | About 4621 | About 4621 (about 5,136M after the September 2026 SPP, derived) |
“—” = not publicly disclosed.
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (AUD Mn) | -5.14 | -9.13 | -5.05 | -4.77 | -5.04 |
Capex incl. capitalised E&E, derived (AUD Mn) | 5.11 | 8.60 | 7.90 | 4.28 | 9.14 |
Free cash flow (AUD Mn) | -10.25 | -17.73 | -12.95 | -9.05 | -14.18 |
Investing cash flow (AUD Mn) | -9.83 | -8.19 | -4.56 | -1.40 | -11.69 |
Financing cash flow (AUD Mn) | 42.92 | -0.22 | -0.25 | 7.87 | 12.78 |
Equity raised, gross (AUD Mn) | — | 0 | 0 | — | 14.03 |
Dividends paid (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Net change in cash (AUD Mn) | 27.95 | -17.55 | -9.86 | 1.71 | -3.95 |
“—” = not publicly disclosed.
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
ROE (% on avg equity) | -9.3 | -5.7 | -4.6 | -3.9 |
ROA (% on avg assets) | -9.1 | -5.6 | -4.5 | -3.8 |
Current ratio (x) | 14.8 | 8.9 | 2.3 | 4.6 |
Debt/equity, leases (x) | 0.005 | 0.005 | 0.004 | 0.002 |
Geographic Revenue
| Region | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Australia revenue (AUD Mn) | 0 | 0 | 0 |
Europe revenue (AUD Mn) | 0 | 0 | 0 |
Asia-Pacific ex-Australia revenue (AUD Mn) | 0 | 0 | 0 |
Americas revenue (AUD Mn) | 0 | 0 | 0 |
Total revenue (AUD Mn) | 0 | 0 | 0 |
Markets
| Market | Product | Channel | Basis |
|---|---|---|---|
Europe (ceramics) | Great White CRM™ | Traxys Europe S.A. | Binding 5-year offtake, July 2024 |
Japan | Great White CRM™ / KCM™ | Plantan Yamada Co Ltd | Offtake, June 2023 |
India and Middle East | Great White CRM™ | Managed by Traxys | Per offtake terms |
Concrete markets | Great White HRM™ | Traxys plus conditional offtakes | Binding, with conditions on some |
United States | 4N HPA | Traxys North America | Non-binding HoA, August 2026 |
Share Price & Returns
| Reference point | Price (AUD) | Source / date |
|---|---|---|
MEP final trade (pre-merger entity) | 0.205 | InvestSMART, 10 March 2022 |
ADN 5-year high (approximate) | 0.26 | MarketScreener 5-year range |
ADN at HPA Scoping Study | 0.024 | 18 September 2025 |
ADN at start of 2026 (implied) | 0.014 | Derived from the YTD change of -57.14% |
ADN at 31 March 2026 update | 0.010 | InvestSMART |
ADN SPP issue price | 0.0059 | 4 September 2026 |
ADN latest | 0.006 | 9 October 2026 |
Valuation Multiples
| Multiple | ADN | Comment |
|---|---|---|
Market cap | About A$30.8M | MarketScreener (October 2026) |
Enterprise value | About A$25M (derived: market cap less about A$6M pro-forma cash after the SPP, no debt) | MarketScreener shows A$105M, apparently on forecast net debt (Merricks); treat with caution |
P/E | N/M (loss-making) | — |
EV/EBITDA | N/M | — |
EV/Sales | N/M | MarketScreener's FY2028E EV/Sales of 5.74x relies on a single forecast |
P/B | About 0.35 (Eulerpool, August 2026); about 0.44 on 31 December 2025 equity (derived) | Market values the company well below post-impairment book |
Capital Markets
| Item | Detail |
|---|---|
Dividend history / policy | None paid; no policy (pre-revenue) |
Credit ratings (Moody's / S&P / Fitch) | Not rated |
Debt maturity profile | No borrowings. Leases about A$0.26M (31 December 2025). Merricks A$75M facility undrawn and unexecuted |
Listed options | About 293.5M, exercise A$0.0195, expiring 2 July 2027 (deeply out of the money) |
Analyst Conclusions
Management guidance
-
About A$40M of equity is needed, alongside the A$75M Merricks debt, to reach FID on Stage 1A+.
-
Continued engagement with a Middle East cornerstone investor, plus evaluation of "funding, strategic and corporate opportunities".
-
HPA commercial samples in H2 2026; a PFS subject to funding.
-
Operating cash outflows expected to fall after early works and cost savings (Appendix 5B commentary, 31 July 2026).
Consensus
There is no reliable consensus. The stale aggregator forecast of a A$34M profit in FY2027 is not credible without FID.
Bull case
-
The cornerstone deal closes. Due diligence is complete and terms had reached final stages before the geopolitical delay. Closing the about A$40M would unlock the A$75M Merricks facility and fully fund Stage 1A+, with permits, offtake and long-lead equipment already in place.
-
HPA re-rates the company. Pilot-scale 4N HPA (99.9986%), a US pathway through Traxys and Project Vault, and a scoping NPV of about A$1.48bn could attract strategic capital disproportionate to the about A$31M market cap.
-
Asset value is well below replacement cost. P/B is about 0.35–0.44 even after a A$99M write-down, the early-works spend is sunk, and R&D refunds (43.5% on about A$26M) reduce net capex.
Bear case
-
Funding gap versus market cap. About A$40M of equity against about A$31M market cap means any equity solution is likely to be highly dilutive or to sit at asset level, capturing value away from ordinary shareholders.
-
Liquidity is thin. Less than two quarters of runway even after the A$3.04M SPP, plus an auditor going-concern flag. A failed process could force a distressed sale or recapitalisation.
-
HPA is early stage. HPA remains pre-PFS, needs about A$155M of capex itself, and faces entrenched incumbents and better-funded Australian peers. Kaolin offtake pricing is only fixed for two years.
Key catalysts and monitorables (next 12 months)
-
September 2026 quarterly report (due about 29 October 2026): cash, burn and status of the cornerstone process.
-
Execution or failure of the cornerstone equity agreement; Merricks binding documentation and first drawdown.
-
Appointment of a permanent CEO.
-
HPA customer sample feedback and any binding HPA offtake (conversion of the Traxys North America HoA).
-
Commencement of an HPA PFS and any government or critical-minerals funding (Australian or US EXIM / Project Vault).
-
Further equity raises: pricing and dilution.
-
Any corporate transaction (merger, asset sale or strategic partner) flagged under "corporate opportunities".
-
Status of the long-lead equipment and Traxys offtake terms if FID slips into 2027.
Analyst verdict
Minotaur Exploration's legacy now lives in two places. The copper-gold half sits inside AIC Mines. The kaolin half, Minotaur's founding 25% stake in Great White, sits inside Andromeda Metals.
For anyone tracking the MEP line, Andromeda is the relevant security, and its 2022–2026 record has been value-destructive. The ADN shares issued for each MEP share are worth well under a cent today, against A$0.205 at delisting.
Operationally, Andromeda has done most of what a developer can do without capital. Great White is permitted, engineered and offtaken. Early works are complete, and key equipment is in Australia. Debt is credit-approved. The HPA flowsheet, potentially the more valuable idea, has crossed from laboratory to continuous pilot at 4N purity and has a credible US route to market through Traxys.
The problem is entirely financial. With A$3.2M of cash at June 2026, topped up by A$3.0M in September, a going-concern flag and an about A$40M equity gap larger than its market value, Andromeda's negotiating position with capital providers is weak. The roughly A$99M FY2026 write-down shows the board itself accepting a lower carrying value. The leadership structure, with an acting CEO since 2024 and a new CFO, adds execution risk exactly when credibility with investors matters most.
Our assessment is that ADN is a binary, special-situation equity. If an asset-level cornerstone deal closes on reasonable terms, the stock could re-rate sharply given the low P/B and the HPA optionality. However, the most probable outcomes are heavy dilution or a value-sharing structure at project level, and the downside includes recapitalisation if funding fails before cash runs out.
Monitoring priority: the cornerstone outcome, cash runway and the CEO appointment. Until FID is achieved, we view the risk/reward as speculative, with downside skew for existing shareholders.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure / appointment | Background (as disclosed) |
|---|---|---|---|
Sarah Clarke | Acting Chief Executive Officer (also General Counsel and Company Secretary) | General Counsel/CoSec from 9 January 2023; Acting CEO since 11 September 2024 | LLB (Hons), BSc, Grad Cert (Applied Finance and Investment) |
Keith Pollocks | Chief Financial Officer | Appointed July 2026 (announced 13 July 2026) | More than 30 years in senior finance roles across resources, mining, infrastructure, banking and industrials |
Joseph (Joe) Ranford | Chief Operating Officer | Since about April 2020 (MarketScreener) | Not detailed in sources reviewed |
Patrick Sinclair | Manager, Investor Relations & Corporate Affairs | — | — |
“—” = not publicly disclosed.
Board of Directors
| Name | Role | Independence | Notes |
|---|---|---|---|
Sue-Ann Higgins | Executive Chair | Not independent (executive) | Executive Chair since 11 September 2024; accepting reduced fees |
Mick Wilkes | Non-Executive Director | Not stated | Assists with GWP financing; waived all director fees until GWP is fully financed |
Miguel J. Galindo | Non-Executive Director (effective 16 January 2025) | Not stated (prior consulting/marketing role for ADN) | Chemical engineer; President of the Spanish Glass & Ceramics Society (SECV); NED at Port-Sur (Port of Castellón); oversees European market relations |
Jean-Dominique Sorel | Non-Executive Director | Not stated | — |
Directors' Remuneration
| Role | Total remuneration (A$, FY2025) | Holding (%) |
|---|---|---|
Executive Chair (Sue-Ann Higgins) | 149,690 | 0.030 |
Independent NED | 16,670 | 0.082 |
NED | 99,280 | 0.037 |
NED | 177,200 | — |
“—” = not publicly disclosed.
Major Shareholders
| Holder category | Detail |
|---|---|
Top 10 institutional holders | Not publicly disclosed in sources reviewed. No substantial-holder (>5%) notices were identified; see the FY2026 Annual Report top-20 schedule |
ETF ownership | None (InvestSMART) |
Free float | About 88–99% (MarketScreener, varying by date) |
Insider ownership | Board holdings individually below 0.1% each (Simply Wall St) |
Retail base | Large. 342 holders participated in the September 2026 SPP |
Competitive Landscape
Key Competitors
| Competitor | Segment overlap | Scale / positioning (qualitative) | Relative to ADN |
|---|---|---|---|
Imerys (France) | Kaolin, ceramics minerals | Global industrial-minerals leader with multi-billion-euro revenue and integrated mines worldwide | Incumbent supplier to ADN's target ceramics customers; vastly larger |
Sibelco (Belgium) | Kaolin, ball clay, silica | Global, private, multi-billion-euro | Incumbent in European ceramics |
Kaolin AD (Bulgaria) | Kaolin, quartz sand | Regional European producer | Direct European ceramics competitor |
Thiele Kaolin / KaMin-CADAM (US/Brazil) | Kaolin (paper, coatings, ceramics) | Major Americas producers | Indirect (different end-markets) |
Suvo Strategic Minerals (ASX: SUV) | Kaolin (Pittong, Victoria) | Small Australian producer | Closest listed Australian kaolin peer |
Sumitomo Chemical (Japan) | HPA | Global HPA leader (alkoxide route) | Incumbent in 4N/5N HPA |
Sasol (South Africa / Germany) | HPA | Large established HPA producer | Incumbent |
Baikowski (France) | HPA / specialty alumina | Specialist producer | Incumbent in high-spec niches |
Alpha HPA (ASX: A4N) | HPA (Gladstone, Qld) | Australian HPA developer/producer with government support | Most direct Australian HPA competitor; further advanced |
FYI Resources (ASX: FYI) | HPA (WA, kaolin feed) | Australian HPA developer | Similar kaolin-to-HPA concept |
Chinese HPA producers (various) | HPA | Dominant volume suppliers | Price-setters; geopolitical substitution creates an opening for ADN |
Competitor Detail
| Metric | Andromeda (ADN) |
|---|---|
Revenue | Nil (FY2026) |
Revenue growth | N/M |
EBITDA margin | N/M (EBITDA -A$6.2M) |
R&D intensity | N/M (R&D A$0.9M) |
Stage | Pre-FID developer |
Recent Developments
--



